NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪16.53 M‬USD
−2.46USD
‪−12.47 M‬USD
‪1.97 M‬
Beta (1Y)
0.74

About NeuroBo Pharmaceuticals, Inc.

CEO
Hyung-Heon Kim
Headquarters
Cambridge
Employees (FY)
8
Founded
2014
ISIN
US64132R4048
FIGI
BBG009YPPXR8
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NRBO is 3.37 USD — it has decreased by 2.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroBo Pharmaceuticals, Inc. stocks are traded under the ticker NRBO.
NeuroBo Pharmaceuticals, Inc. is going to release the next earnings report on May 21, 2024. Keep track of upcoming events with our Earnings Calendar.
NRBO stock is 7.06% volatile and has beta coefficient of 0.74. Check out the list of the most volatile stocks — is NeuroBo Pharmaceuticals, Inc. there?
One year price forecast for NeuroBo Pharmaceuticals, Inc. has a max estimate of 48.00 USD and a min estimate of 25.00 USD.
NRBO earnings for the last quarter are −0.72 USD per share, whereas the estimation was −0.88 USD resulting in a 18.18% surprise. The estimated earnings for the next quarter are −0.79 USD per share. See more details about NeuroBo Pharmaceuticals, Inc. earnings.
Yes, you can track NeuroBo Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
NRBO stock has fallen by 5.87% compared to the previous week, the month change is a 18.60% fall, over the last year NeuroBo Pharmaceuticals, Inc. has showed a 40.67% decrease.
NRBO net income for the last quarter is ‪−5.31 M‬ USD, while the quarter before that showed ‪−3.82 M‬ USD of net income which accounts for −39.18% change. Track more NeuroBo Pharmaceuticals, Inc. financial stats to get the full picture.
Today NeuroBo Pharmaceuticals, Inc. has the market capitalization of ‪16.53 M‬, it has increased by 1.02% over the last week.
No, NRBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NRBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroBo Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NRBO reached its all-time high on Aug 1, 2017 with the price of 129540.00 USD, and its all-time low was 0.60 USD and was reached on Oct 22, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 22, 2024, the company has 8.00 employees. See our rating of the largest employees — is NeuroBo Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroBo Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroBo Pharmaceuticals, Inc. stock shows the sell signal. See more of NeuroBo Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NeuroBo Pharmaceuticals, Inc. future price: according to them, NRBO price has a max estimate of 48.00 USD and a min estimate of 25.00 USD. Read a more detailed NeuroBo Pharmaceuticals, Inc. forecast: see what analysts think of NeuroBo Pharmaceuticals, Inc. and suggest that you do with its stocks.